CHMMF
Chimeric Therapeutics Limited
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.001
- Prev close
- 0.10
- Mkt cap
- 14.75M
- Vol
- 30.00K
- Avg vol
- 0
- EPS
- -1.12
- P/E
- 0.00
More statistics
- Low
- 0.001
- High
- 0.001
News
10 months ago proactiveinvestors.com
Chimeric Therapeutics secures FDA Orphan Drug Designation for CHM CDH17 in gastric cancer
Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its CHM CDH17 cell...
10 months ago proactiveinvestors.com
Imugene secures FDA backing for Azer-cel registration pathway
Imugene Ltd (ASX:IMU, OTC:IUGNF) has won crucial backing from the US Food and Drug Administration (FDA), with written minutes from a recent Type C meeting...
10 months ago proactiveinvestors.com
Kairos Minerals secures mining agreement with Nyamal Aboriginal Corporation for Mt York Gold Project
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has signed a Mining Agreement with Nyamal Aboriginal Corporation (NAC) covering the Mt York Gold Project in the...
11 months ago proactiveinvestors.com
Chimeric Therapeutics receives $4.5 million R&D tax incentive refund
Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received a research and development (R&D) tax incentive refund of $4,497,886 under the Australian...
11 months ago proactiveinvestors.com
Altech draws interest from top-tier battery manufacturer as Silumina Anodes™ hit 1,000-cycle mark
Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) has attracted fresh industry attention after one of the world’s largest electric vehicle battery manufacturers...
11 months ago proactiveinvestors.com
Vaultz completes Xapo Bank onboarding
Vaultz Capital PLC (AQSE:V3TC, OTCQB:VZTCF) told investors it has completed onboarding with Xapo Bank, marking the start of a new custody arrangement for...